List of Soligenix patents

List of Soligenix patents

List of Tensorcom patents

List of Osram patents

List of Synack patents

List of NGOs in Princeton, New Jersey

List of companies in Hotung Venture Group's investment portfolio

Patents where

Current Assignee

Name

is

Soligenix

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11311598 Peptides and analogs for use in the treatment of oral mucositis	Patent 11311598 was granted and assigned to Soligenix on April, 2022 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	11311598	April 26, 2022
	‌ US Patent 9850279 Peptides and analogs for use in the treatment of oral mucositis	Patent 9850279 was granted and assigned to Soligenix on December, 2017 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	9850279	December 26, 2017
	‌ US Patent 10253068 Peptides and analogs for use in the treatment of oral mucositis	Patent 10253068 was granted and assigned to Soligenix on April, 2019 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	10253068	April 9, 2019
	‌ US Patent 10526268 Systems and methods for producing synthetic hypericin	Patent 10526268 was granted and assigned to Soligenix on January, 2020 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	10526268	January 7, 2020
	‌ US Patent 10053413 Systems and methods for producing synthetic hypericin	Patent 10053413 was granted and assigned to Soligenix on August, 2018 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	10053413	August 21, 2018
	‌ US Patent 10293041 Multivalent stable vaccine composition and methods of making same	Patent 10293041 was granted and assigned to Soligenix on May, 2019 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	10293041	May 21, 2019
	‌ US Patent 9416157 Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity	Patent 9416157 was granted and assigned to Soligenix on August, 2016 by the United States Patent and Trademark Office.		Soligenix		United States Patent and Trademark Office	9416157	August 16, 2016
	‌ US Patent 9763963 Topically active steroids for use in interstitial pulmonary fibrosis	Patent 9763963 was granted and assigned to Soligenix on September, 2017 by the United States Patent and Trademark Office.	Soligenix	Soligenix		United States Patent and Trademark Office	9763963	September 19, 2017
	‌ US Patent 9168263 Topically active steroids for use in interstitial pulmonary fibrosis	Patent 9168263 was granted and assigned to Soligenix on October, 2015 by the United States Patent and Trademark Office.		Soligenix		United States Patent and Trademark Office	9168263	October 27, 2015
	‌ US Patent 8791061 Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity	Patent 8791061 was granted and assigned to Soligenix on July, 2014 by the United States Patent and Trademark Office.		Soligenix		United States Patent and Trademark Office	8791061	July 29, 2014
	‌ US Patent 8263582 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids	Patent 8263582 was granted and assigned to Soligenix on September, 2012 by the United States Patent and Trademark Office.		Soligenix		United States Patent and Trademark Office	8263582	September 11, 2012
	‌ US Patent 8535650 Stabilized reverse micelle compositions and uses thereof			Soligenix		United States Patent and Trademark Office	8535650	September 17, 2013

12 results

0 selected

12 results

0 selected